We are live on !
Find out more
Brown Advisory Portfolio holdings
AUM
$64.6B
Turnover
14.74%
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+18.98%
3 Year Est. Return
+84.85%
5 Year Est. Return
+98.36%
10 Year Est. Return
+536.38%
AUM
$30.7B
AUM Growth
-$701M
(-2.2%)
Cap. Flow
-$734M
Cap. Flow % of AUM
Cap. Flow %
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
26.64%
Holding
969
New
40
Increased
169
Reduced
587
Closed
106
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$252M |
| 2 |
Costco
COST
|
+$107M |
| 3 |
Amazon
AMZN
|
+$69.7M |
| 4 |
W.P. Carey
WPC
|
+$55.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$48.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WFM
Whole Foods Market Inc
WFM
|
+$144M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$119M |
| 3 |
Gilead Sciences
GILD
|
+$113M |
| 4 |
Charles Schwab
SCHW
|
+$95.8M |
| 5 |
DaVita
DVA
|
+$91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.72% |
| 2 | Healthcare | 19.09% |
| 3 | Financials | 13.6% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Visa
V
$785B
| $992M | 3.23% |
14,777,368
-1,048,489
| -7% | -$71.1M |
2013 Q2
8 quarters
|
|
|
ESRX
2
DELISTED
Express Scripts Holding Company
ESRX
| $979M | 3.19% |
11,002,598
-1,366,638
| -11% | -$119M |
2013 Q2
8 quarters
|
|
|
3
Charles Schwab
SCHW
$159B
| $935M | 3.05% |
28,646,491
-3,031,825
| -10% | -$95.8M |
2013 Q2
8 quarters
|
|
4
Apple
AAPL
$5.05T
| $894M | 2.91% |
28,509,948
-1,486,276
| -5% | -$47.5M |
2013 Q2
8 quarters
|
|
|
5
Amazon
AMZN
$2.95T
| $793M | 2.58% |
36,521,020
+3,335,300
| +10% | +$69.7M |
2013 Q2
8 quarters
|
|
6
Starbucks
SBUX
$122B
| $785M | 2.56% |
14,638,423
-483,951
| -3% | -$24.6M |
2013 Q2
8 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$3.61T
| $779M | 2.54% |
29,379,260
-679,119
| -2% | -$18.2M |
2013 Q2
8 quarters
|
|
8
Meta Platforms (Facebook)
META
$1.63T
| $707M | 2.3% |
8,243,124
+291,609
| +4% | +$23.8M |
2013 Q2
8 quarters
|
|
9
DELISTED
Stericycle Inc
SRCL
| $663M | 2.16% |
4,952,740
-157,965
| -3% | -$21.7M |
2013 Q2
8 quarters
|
|
10
Danaher
DHR
$162B
| $656M | 2.14% |
11,400,458
-347,048
| -3% | -$19.9M |
2013 Q2
8 quarters
|
|
11
Intuitive Surgical
ISRG
$162B
| $616M | 2.01% |
11,442,330
-962,019
| -8% | -$53.8M |
2013 Q2
8 quarters
|
|
12
Estee Lauder
EL
$40.8B
| $613M | 2% |
7,072,175
-242,784
| -3% | -$20.9M |
2013 Q2
8 quarters
|
|
13
Salesforce
CRM
$177B
| $590M | 1.92% |
8,476,738
-292,913
| -3% | -$20.9M |
2013 Q2
8 quarters
|
|
14
Amphenol
APH
$188B
| $579M | 1.88% |
79,847,376
-2,613,264
| -3% | -$18.8M |
2013 Q2
8 quarters
|
|
15
Ecolab
ECL
$84.9B
| $567M | 1.85% |
5,015,870
-160,725
| -3% | -$18.5M |
2013 Q2
8 quarters
|
|
16
TripAdvisor
TRIP
$854M
| $548M | 1.78% |
6,288,951
+434,259
| +7% | +$35.3M |
2014 Q4
2 quarters
|
|
|
MJN
17
DELISTED
Mead Johnson Nutrition Company
MJN
| $547M | 1.78% |
6,061,167
-261,795
| -4% | -$25.2M |
2013 Q2
8 quarters
|
|
|
18
Costco
COST
$465B
| $538M | 1.75% |
3,984,856
+746,394
| +23% | +$107M |
2013 Q2
8 quarters
|
|
|
19
Bristol-Myers Squibb
BMY
$127B
| $523M | 1.7% |
7,858,899
+730,906
| +10% | +$48.2M |
2013 Q2
8 quarters
|
|
20
Cognizant
CTSH
$28.7B
| $520M | 1.69% |
8,508,597
-285,449
| -3% | -$17.9M |
2013 Q2
8 quarters
|
|
21
NXP Semiconductors
NXPI
$62.7B
| $514M | 1.67% |
5,237,350
+150,974
| +3% | +$15.5M |
2014 Q4
2 quarters
|
|
22
SLB Ltd
SLB
$73.4B
| $465M | 1.52% |
5,398,260
-182,989
| -3% | -$16.5M |
2013 Q2
8 quarters
|
|
|
23
DaVita
DVA
$12B
| $457M | 1.49% |
5,756,414
-1,108,325
| -16% | -$91M |
2013 Q2
8 quarters
|
|
|
24
Gilead Sciences
GILD
$207B
| $453M | 1.48% |
3,870,411
-1,030,225
| -21% | -$113M |
2013 Q2
8 quarters
|
|
25
Fastenal
FAST
$61.5B
| $453M | 1.47% |
42,945,324
-1,635,504
| -4% | -$17.2M |
2013 Q2
8 quarters
|
|
Similar funds
Brown Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Brown Advisory held 969 positions worth $30.7B, down 2.2% from $31.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Brown Advisory's Q2 2015 filing shows 40 new, 169 increased, 587 reduced and 106 closed positions. Its largest new stake was Archrock: 707,748 shares worth $23.1M. The largest sale was Whole Foods Market Inc, an estimated $144M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q2 2015 buy was Archrock: 707,748 shares worth $23.1M.
- Brown Advisory added most to Alexion Pharmaceuticals in Q2 2015, an estimated $252M increase.
- Brown Advisory's biggest Q2 2015 reduction was Whole Foods Market Inc, cutting an estimated $144M.
- Brown Advisory fully exited ARUBA NETWORKS, INC. in Q2 2015, selling an estimated $38.7M.
- Brown Advisory's ten largest holdings make up 27% of its $30.7B portfolio in Q2 2015.
- Brown Advisory opened 40 new positions and closed 106 in Q2 2015.
- Brown Advisory's portfolio value fell 2.2% quarter-over-quarter to $30.7B.
Based on Brown Advisory's 13F filing for Q2 2015, filed 11 Aug 2015.